CFO SpotlightsCareers of chief financial officers, from the filings. Records as of October 28, 2026
  1. CFO Spotlights
  2. Profiles
  3. W. Andrew Macan

Profile

W. Andrew Macan

Chief Financial Officer, Neuronetics, Inc.

Former. First published here October 28, 2026; built from records as of October 28, 2026.

Neuronetics, Inc. named Nir Naor to succeed W. Andrew Macan, effective July 23, 2026.1

Seats

The seat in the record

CompanyTitle as filedStandingFilings
Neuronetics, Inc. (STIM)
Surgical & Medical Instruments & Apparatus
Not statedFormer1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

  1. July 23, 2026effective

    Neuronetics, Inc. named Nir Naor to succeed W. Andrew Macan, effective July 23, 2026. Profile of Nir Naor.

    [1] Filing by Neuronetics, Inc., filed with the SEC on July 20, 2026. Read the filing. The record at CFO Tribune.

Sources

Sources

  1. Current report filed with the SEC, Neuronetics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed July 20, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or W. Andrew Macan wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.